Terumo Corporation (TRUMF)

Market Cap	20.20B -27.8%
Revenue (ttm)	7.18B +7.7%
Net Income	882.98M +9.4%
EPS	0.60 +10.1%
Shares Out	n/a
PE Ratio	22.88
Forward PE	n/a
Dividend	0.20 (1.52%)
Ex-Dividend Date	Mar 30, 2026

Volume	17,600
Average Volume	10,263
Open	12.95
Previous Close	13.09
Day's Range	12.95 - 13.74
52-Week Range	12.51 - 20.58
Beta	0.23
RSI	50.61
Earnings Date	Feb 13, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRUMF

Financial Performance

In fiscal year 2025, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.

Financial numbers in JPY